LPL Financial’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.57M Buy
63,897
+7,007
+12% +$456K ﹤0.01% 2544
2026
Q1
$2.7M Buy
56,890
+3,847
+7% +$172K ﹤0.01% 3228
2025
Q4
$1.68M Buy
53,043
+17,644
+50% +$550K ﹤0.01% 3558
2025
Q3
$996K Buy
35,399
+6,685
+23% +$202K ﹤0.01% 4005
2025
Q2
$1.06M Sell
28,714
-436
-1% -$15.1K ﹤0.01% 3707
2025
Q1
$1.14M Sell
29,150
-20,732
-42% -$934K ﹤0.01% 3440
2024
Q4
$2.32M Sell
49,882
-6,462
-11% -$292K ﹤0.01% 2727
2024
Q3
$2.55M Buy
56,344
+21,480
+62% +$1.02M ﹤0.01% 2501
2024
Q2
$1.72M Buy
34,864
+5,876
+20% +$240K ﹤0.01% 2742
2024
Q1
$995K Sell
28,988
-1,647
-5% -$59.4K ﹤0.01% 3185
2023
Q4
$1.13M Sell
30,635
-7,203
-19% -$167K ﹤0.01% 2934
2023
Q3
$767K Sell
37,838
-1,269
-3% -$27.9K ﹤0.01% 3129
2023
Q2
$800K Buy
39,107
+11,953
+44% +$179K ﹤0.01% 3034
2023
Q1
$409K Buy
27,154
+4,531
+20% +$100K ﹤0.01% 3494
2022
Q4
$539K Buy
22,623
+8,330
+58% +$242K ﹤0.01% 3189
2022
Q3
$504K Buy
14,293
+130
+0.9% +$5.52K ﹤0.01% 3147
2022
Q2
$495K Buy
14,163
+767
+6% +$27.2K ﹤0.01% 3210
2022
Q1
$661K Buy
13,396
+3,268
+32% +$181K ﹤0.01% 2970
2021
Q4
$784K Buy
10,128
+8,089
+397% +$830K ﹤0.01% 2871
2021
Q3
$218K Sell
2,039
-81
-4% -$9.28K ﹤0.01% 3907
2021
Q2
$282K Sell
2,120
-731
-26% -$85K ﹤0.01% 3637
2021
Q1
$353K Buy
2,851
+716
+34% +$109K ﹤0.01% 3342
2020
Q4
$302K Buy
+2,135
New +$237K ﹤0.01% 3195

Other funds holding TWST

LPL Financial's TWST Position: Q2 2026 in Review

LPL Financial increased its Twist Bioscience (TWST) stake by 12% in Q2 2026, buying an estimated $456K and bringing the position to 63,897 shares worth $6.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2544.

LPL Financial first reported a position in TWST in Q4 2020 and has held it in 23 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • LPL Financial held 63,897 shares of Twist Bioscience worth $6.57M as of Q2 2026.
  • LPL Financial bought 7,007 Twist Bioscience shares in Q2 2026, an estimated $456K.
  • Twist Bioscience made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #2544 holding.
  • LPL Financial first reported a position in Twist Bioscience in Q4 2020 and has held it in 23 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.